Biomarkers of intestinal permeability are associated with inflammation in metabolically healthy obesity but not normal-weight obesity

被引:0
|
作者
Keirns, Bryant H. [1 ]
Medlin, Austin R. [2 ]
Maki, Katherine A. [3 ]
McClanahan, Kristen [4 ]
Fruit, Sarah E. [1 ]
Sciarrillo, Christina M. [4 ]
Hart, Samantha M. [4 ]
Joyce, Jill [4 ]
Lucas, Edralin A. [4 ]
Emerson, Sam R. [4 ]
机构
[1] Ball State Univ, Dept Nutr & Hlth Sci, Muncie, IN 47306 USA
[2] Indiana Univ, Sch Publ Hlth, Dept Hlth & Wellness Design, Bloomington, IN USA
[3] NIH, Translat Biobehav & Hlth Dispar Branch, Clin Ctr, Bethesda, MD USA
[4] Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2024年 / 327卷 / 05期
关键词
cardiovascular disease; gut permeability; inflammation; metabolically healthy obesity; normal-weight obesity; INSULIN-RESISTANCE; OXIDATIVE STRESS; GUT PERMEABILITY; EATING INDEX; SERUM-LEVELS; INDIVIDUALS; MARKERS; ENDOTOXEMIA; DYSFUNCTION; MORTALITY;
D O I
10.1152/ajpheart.00381.2024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic inflammation is reported in normal-weight obesity (NWO) and metabolically healthy obesity (MHO), which may be linked to their increased cardiovascular disease (CVD) risk. Yet, drivers of this inflammation remain unclear. We characterized factors known to influence inflammatory status (i.e., intestinal permeability, adipose tissue, diet quality, microbiota), and their relationships with measured inflammation, in NWO and MHO, healthy control subjects (CON), and metabolically unhealthy obesity (MUO; N = 80; n = 20/group). Serum indicators of intestinal permeability and inflammation were assessed by ELISA and/or multiplex. Total, visceral, and percent body fat were measured with dual-energy X-ray absorptiometry (DXA). Fecal microbiota composition was assessed via 16S rRNA sequencing (n = 9-10/group). For C-reactive protein (CRP), MUO > NWO > CON (P < 0.0001). In MHO, CRP was intermediate and similar to both MUO and NWO. Lipopolysaccharide binding protein (LBP) and the ratio of LBP to soluble CD14 (sCD14) were higher in MHO and MUO vs. CON/NWO (P < 0.0001). Across correlation and regression analyses, LBP consistently displayed the strongest relationships with CRP in the entire sample (r = 0.78; beta = 0.57; P < 0.0001) and in MHO (r = 0.74; P < 0.01) but not NWO (r = 0.37; P = 0.11). Shannon index was higher in CON compared with MUO (P < 0.05) and inversely correlated with CRP in the full sample (r = -0.37; P < 0.05). These data are consistent with the notion that intestinal permeability is associated with low-grade inflammation in MHO, which could be implicated in this population's reported CVD risk. NEW & NOTEWORTHY This is the first study to our knowledge to examine biomarkers of intestinal permeability in normal-weight obesity and one of few assessing microbiota compositions in this population. Additionally, we report that individuals with metabolically healthy obesity and metabolically unhealthy obesity displayed similar evidence of intestinal permeability, which was more strongly associated with systemic inflammation than total and visceral adipose tissue mass.
引用
收藏
页码:H1135 / H1145
页数:11
相关论文
共 50 条
  • [41] Characterising metabolically healthy obesity in weight-discordant monozygotic twins
    Naukkarinen, J.
    Heinonen, S.
    Hakkarainen, A.
    Lundbom, J.
    Vuolteenaho, K.
    Saarinen, L.
    Hautaniemi, S.
    Rodriguez, A.
    Fruehbeck, G.
    Pajunen, P.
    Hyotylainen, T.
    Oresic, M.
    Moilanen, E.
    Suomalainen, A.
    Lundbom, N.
    Kaprio, J.
    Rissanen, A.
    Pietilainen, K. H.
    DIABETOLOGIA, 2014, 57 (01) : 167 - 176
  • [42] Characterising metabolically healthy obesity in weight-discordant monozygotic twins
    J. Naukkarinen
    S. Heinonen
    A. Hakkarainen
    J. Lundbom
    K. Vuolteenaho
    L. Saarinen
    S. Hautaniemi
    A. Rodriguez
    G. Frühbeck
    P. Pajunen
    T. Hyötyläinen
    M. Orešič
    E. Moilanen
    A. Suomalainen
    N. Lundbom
    J. Kaprio
    A. Rissanen
    K. H. Pietiläinen
    Diabetologia, 2014, 57 : 167 - 176
  • [43] Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans
    Choi, Kyung Mook
    Cho, Hyun Joo
    Choi, Hae Yoon
    Yang, Sae Jeong
    Yoo, Hye Jin
    Seo, Ji A.
    Kim, Sin Gon
    Baik, Sei Hyun
    Choi, Dong Seop
    Kim, Nan Hee
    CLINICAL ENDOCRINOLOGY, 2013, 79 (03) : 364 - 370
  • [44] Is metabolically healthy obesity a useful concept?
    Beh, S.
    DIABETIC MEDICINE, 2019, 36 (05) : 539 - 545
  • [45] Metabolically healthy obesity in a paediatric obesity clinic
    Teixeira, Diana
    Martins, Catia
    Oliveira, Guiomar
    Soares, Raquel
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2022, 35 (09) : 1147 - 1153
  • [46] Metabolically healthy obesity: Inflammatory biomarkers and adipokines in elderly population
    Cobos-Palacios, Lidia
    Isabel Ruiz-Moreno, Maria
    Vilches-Perez, Alberto
    Vargas-Candela, Antonio
    Munoz-Ubeda, Monica
    Benitez Porres, Javier
    Navarro-Sanz, Ana
    Dolores Lopez-Carmona, Maria
    Sanz-Canovas, Jaime
    Perez-Belmonte, Luis M.
    Jose Mancebo-Sevilla, Juan
    Gomez-Huelgas, Ricardo
    Rosa Bernal-Lopez, Maria
    PLOS ONE, 2022, 17 (06):
  • [47] Children With Metabolically Healthy Obesity: A Review
    Vukovic, Rade
    Dos Santos, Tiago Jeronimo
    Ybarra, Marina
    Atar, Muge
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [48] Prevalence and Predictors of Normal-Weight Obesity among Women
    Parfenteva, Olga I.
    Kulemin, Nikolay A.
    Bondareva, Elvira A.
    Ahmetov, Ildus I.
    NUTRIENTS, 2024, 16 (16)
  • [49] Metabolically Healthy Obesity and Bariatric Surgery
    Catoi, Adriana Florinela
    Busetto, Luca
    OBESITY SURGERY, 2019, 29 (09) : 2989 - 3000
  • [50] 'Metabolically healthy obesity': Origins and implications
    Denis, Gerald V.
    Obin, Martin S.
    MOLECULAR ASPECTS OF MEDICINE, 2013, 34 (01) : 59 - 70